Anti-Cancer Medicines Availability: European Study

AntiNeoplastics Medicines Availability study Europe banner

Study objectives: to provide European health authorities with data on the availability of licensed anti-neoplastic medicines across Europe

The results of the European study have been published in the August 2016 issue of Annals of Oncology

Study objective

The goals of this study are:

  • to provide European health authorities with data on the availability of licensed anti-neoplastic medicines across Europe
  • to report on the actual availability of anti-neoplastic medicines to patients when they are prescribed and when patients can afford them
  • to provide data so that the European Union and the European Medicines Agency can decide how to best address and resolve the challenges identified

 Read the manuscript here

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings